Immunotech Biopharm Ltd (6978.HK) HKSE

2.68

-0.07(-2.55%)

Updated at December 24 12:08PM

Currency In HKD

Valuation

Market Cap1.11B
Enterprise Value1.18B
P/E Ratio-5.56
PEG Ratio0.29
Price/Sales Ratio0
Price/Book Ratio-8.73
Enterprise/Revenue0
Enterprise/EBITDA-10.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.46
Return On Equity2.87

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-148.68M
Net Income-186.91M
Diluted EPS-0.36

Balance Sheet

Total Cash21.05M
Total Cash/Share0.04
Total Debt111.73M
Total Debt/Equity-0.78
Current Ratio0.08
Book Value Per Share-0.28

Price History

52-Week Change19.11
52-Week High6.15
52-Week Low2.2
Moving Average 50 Days3.15
Moving Average 200 Days3.81

Statistics

Average Volume1.46M
Shares Outstanding513.49M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A